Funder
Project supported by the Natural Science Foundation of Liaoning pvovince,China
Project supported by the Jinzhou Foundation for Science and Technology, China
Publisher
Springer Science and Business Media LLC
Subject
Complementary and alternative medicine,Pharmacology
Reference48 articles.
1. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
2. Utiger RD. Insulin and the polycystic ovary syndrome. N Engl J Med. 1996;335(9):657–8.
3. Ouyang X. Drug treatment of clinical application development of polycystic ovary syndrome. J Mod Med Health Care. 2017;33(11):1667–9 (in Chinese).
4. Wang F, Wang SB, Zhang ZH, Lin QQ, Liu YP, Xiao YJ, Xiao KJ, Wang Z. Defective insulin signaling and the protective effects of dimethyldiguanide during follicular development in the ovaries of polycystic ovary syndrome. Mol Med Rep. 2017;16(6):8164–70.
5. Li TT, Mo H, Chen WF. Role of the PI3K-Akt signaling pathway in the pathogenesis of polycystic ovary syndrome. Reprod Sci. 2017;24(5):646–55.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献